Phase II trial of vinorelbine in 120-hours continuous infusion in metastatic breast cancer refractory to anthracyclines

被引：0
|
作者：
Jara, C
Alonso, C
Fernandez, A
GomezAldaravi, L
Arroyo, M
Bosch, C
Tres, A
Gonzalez, M
机构：
[1] HOSP LA PAZ,MADRID,SPAIN
[2] HOSP CLIN,ZARAGOZA,SPAIN
[3] GEN HOSP,SECC ONCOL MED,ALBACETE,SPAIN
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [31] Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer
    Kumar Rajagopalan
    David Peereboom
    G. Thomas Budd
    Thomas Olencki
    Siva Murthy
    Paul Elson
    Denise McLain
    Ronald Bukowski
    Investigational New Drugs, 1998, 16 : 255 - 258
  • [32] A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer
    Mustacchi, G
    Muggia, M
    Milani, S
    Ceccherini, R
    Leita, ML
    Dellach, C
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1730 - 1736
  • [33] Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer
    Anna Tortoriello
    Gaetano Facchini
    Francesco Caponigro
    Michele Santangelo
    Giacomo Benassai
    Giovanni Persico
    Antonio Citarella
    Maria Carola
    Nicola Marzano
    Rosario Vincenzo Iaffaioli
    Breast Cancer Research and Treatment, 1998, 47 : 91 - 97
  • [34] Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer
    Tortoriello, A
    Facchini, G
    Caponigro, F
    Santangelo, M
    Benassai, G
    Persico, G
    Citarella, A
    Carola, M
    Marzano, N
    Iaffaioli, RV
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 47 (01) : 91 - 97
  • [35] Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer
    Rajagopalan, K
    Peereboom, D
    Budd, GT
    Olencki, T
    Murthy, S
    Elson, P
    McLain, D
    Bukowski, R
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (03) : 255 - 258
  • [36] Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion
    Gebbia, V
    Mauceri, G
    Testa, A
    Tirrito, M
    Varvara, F
    Cucchiara, A
    Borsellino, N
    Girlando, A
    Ferrara, M
    Caruso, F
    ANTICANCER RESEARCH, 1999, 19 (3B) : 2289 - 2292
  • [37] A phase II trial of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
    Meshref, M. M.
    Samir, S.
    Saad, E.
    Gouda, Y.
    Elmesidy, S.
    Koheil, H.
    Elzawahri, H.
    Kandil, A.
    Abdelhamid, T.
    Zaki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Ghosn, M
    Kattan, J
    Farhat, F
    Younes, F
    Gasmi, J
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2451 - 2456
  • [39] Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer - A phase II trial
    Elomaa, I
    Joensuu, H
    Blomqvist, C
    ACTA ONCOLOGICA, 2003, 42 (04) : 309 - 314
  • [40] ASSOCIATION OF BOLUS TETRAHYDROPYRANYL ADRIAMYCIN AND 120 HOURS CONTINUOUS 5-FLUOROURACIL INFUSION IN PATIENTS WITH METASTATIC BREAST-CANCER
    CHEVALLIER, B
    FUMOLEAU, P
    KERBRAT, P
    MONNIER, A
    ROCHE, H
    GOUDIE, MJ
    HERAIT, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 : S40 - S43
12345